BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29227198)

  • 21. The status of platinum anticancer drugs in the clinic and in clinical trials.
    Wheate NJ; Walker S; Craig GE; Oun R
    Dalton Trans; 2010 Sep; 39(35):8113-27. PubMed ID: 20593091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymeric biomaterials for the delivery of platinum-based anticancer drugs.
    Kim J; Pramanick S; Lee D; Park H; Kim WJ
    Biomater Sci; 2015 Jul; 3(7):1002-17. PubMed ID: 26221935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The drug targeting and delivery approach applied to pt-antitumour complexes. A coordination point of view.
    Gabano E; Ravera M; Osella D
    Curr Med Chem; 2009; 16(34):4544-80. PubMed ID: 19903151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
    Najjar A; Rajabi N; Karaman R
    Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New-generation platinum agents for solid tumors.
    Shah N; Dizon DS
    Future Oncol; 2009 Feb; 5(1):33-42. PubMed ID: 19243296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platinum formulations as anticancer drugs clinical and pre-clinical studies.
    P Farrell N
    Curr Top Med Chem; 2011; 11(21):2623-31. PubMed ID: 22039867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches.
    Galanski MS; Jakupec MA; Keppler BK
    Curr Med Chem; 2005; 12(18):2075-94. PubMed ID: 16101495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds.
    Zuccolo M; Arrighetti N; Perego P; Colombo D
    Curr Med Chem; 2022; 29(15):2566-2601. PubMed ID: 34365939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefits of enhancing the platinum-free interval in the treatment of relapsed ovarian cancer: more than just a hypothesis?
    Ledermann JA
    Int J Gynecol Cancer; 2011 May; 21 Suppl 1():S9-11. PubMed ID: 21540669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes.
    Pang SK; Yu CW; Au-Yeung SC; Ho YP
    Biochem Biophys Res Commun; 2007 Nov; 363(1):235-40. PubMed ID: 17868646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond platinums: gold complexes as anticancer agents.
    Nardon C; Boscutti G; Fregona D
    Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy.
    Han X; Sun J; Wang Y; He Z
    Med Res Rev; 2015 Nov; 35(6):1268-99. PubMed ID: 26280923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic and biological characteristics of different sugar conjugated 2-methyl malonatoplatinum(II) complexes as new tumor targeting agents.
    Gao X; Liu S; Shi Y; Huang Z; Mi Y; Mi Q; Yang J; Gao Q
    Eur J Med Chem; 2017 Jan; 125():372-384. PubMed ID: 27688191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Research progress in modern structure of platinum complexes.
    Bai L; Gao C; Liu Q; Yu C; Zhang Z; Cai L; Yang B; Qian Y; Yang J; Liao X
    Eur J Med Chem; 2017 Nov; 140():349-382. PubMed ID: 28985575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel platinum(IV) complexes conjugated with a wogonin derivative as multi-targeted anticancer agents.
    Qin X; Xu G; Chen F; Fang L; Gou S
    Bioorg Med Chem; 2017 Apr; 25(8):2507-2517. PubMed ID: 28314511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
    Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K
    Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropilin-1-targeted gold nanoparticles enhance therapeutic efficacy of platinum(IV) drug for prostate cancer treatment.
    Kumar A; Huo S; Zhang X; Liu J; Tan A; Li S; Jin S; Xue X; Zhao Y; Ji T; Han L; Liu H; Zhang X; Zhang J; Zou G; Wang T; Tang S; Liang XJ
    ACS Nano; 2014 May; 8(5):4205-20. PubMed ID: 24730557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Status of non-classical mononuclear platinum anticancer drug development.
    Zhang J; Liu D; Li Y; Sun J; Wang L; Zang A
    Mini Rev Med Chem; 2009 Oct; 9(11):1357-66. PubMed ID: 19929810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The state-of-play and future of platinum drugs.
    Apps MG; Choi EH; Wheate NJ
    Endocr Relat Cancer; 2015 Aug; 22(4):R219-33. PubMed ID: 26113607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.